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In response to cellular genome breaks, MRE11/
RAD50/NBS1 (MRN) activates a global ATM DNA
damage response (DDR) that prevents cellular repli-
cation. Here, we show that MRN-ATM also has
critical functions in defending the cell against DNA
viruses. We reveal temporally distinct responses to
adenovirus genomes: a critical MRN-ATM DDR that
must be inactivated by E1B-55K/E4-ORF3 viral onco-
proteins and a globalMRN-independent ATMDDR to
viral nuclear domains that does not impact viral
replication. We show that MRN binds to adenovirus
genomes and activates a localized ATM response
that specifically prevents viral DNA replication. In
contrast to chromosomal breaks, ATM activation
is not amplified by H2AX across megabases of chro-
matin to induce global signaling and replicative
arrest. Thus, gH2AX foci discriminate ‘‘self’’ and
‘‘non-self’’ genomes and determine whether a local-
ized anti-viral or global ATM response is appropriate.
This provides an elegant mechanism to neutralize
viral genomes without jeopardizing cellular viability.
INTRODUCTION
Central to life is the faithful replication, inheritance, and mainte-
nance of genomic DNA. The MRE11/RAD50/NBS1 (MRN) com-
plex and ATMplay a critical role in this biological mandate (Ciccia
and Elledge, 2010). Cellular double-strand breaks (DSBs) are
sensed by MRN and trigger the assembly of DNA damage
response (DDR) foci that amplify global ATM signaling to induce
cell-cycle arrest and DNA repair (Polo and Jackson, 2011). DNA
viruses are an ancient and persistent threat to both cellular
genome integrity and viability. Adenovirus has a 36 kb linear
double-strand DNA genome that is delivered to the cell nucleus
where it is replicated concomitant with cellular DNA. Thus, the
discovery of adenovirus 5 (Ad5) early proteins that target MRN
excited great interest, suggesting that the cellular DDR also
has an anti-viral role (Figure 1A) (Stracker et al., 2002). However,
despite numerous studies, the role of MRN and global cellular
DDR signaling in defending against adenovirus replication has
been difficult to decipher.
Cellular DSBs are first sensed by MRN that recruits and acti-
vates the apical DDR kinase, ATM, triggering ATM autophos-phorylation at Ser1981 (Lee and Paull, 2004, 2005; Uziel et al.,
2003). The activation of ATM at sites of cellular DSBs is globally
amplified across megabases of flanking chromatin through ATM
phosphorylation of H2AX at Ser139 (gH2AX) (Rogakou et al.,
1999). The MDC1 scaffolding protein binds gH2AX and recruits
additional MRN, ATM, DDR kinases, and effectors into nuclear
foci readily visualized by light microscopy (Polo and Jackson,
2011). gH2AX DDR foci play an important role in nucleating
ATM and effector kinases to induce the global phosphorylation
of DDR substrates, including KAP1, RPA32, 53BP1, and p53,
that elicit cell-cycle arrest, repair, senescence, or apoptosis
(Polo and Jackson, 2011; Soutoglou and Misteli, 2008). ATR
and DNA-PK share some overlapping substrates with ATM,
such as H2AX, but also have independent targets (Ciccia and El-
ledge, 2010).
The assembly of DDR foci is conserved from yeast to humans
and is considered one of the most sensitive hallmarks of cellular
genotoxic stress (Lisby et al., 2004). However, in contrast to
MRN components (Luo et al., 1999; Xiao and Weaver, 1997;
Zhu et al., 2001), H2AX- and MDC1-null mice are viable and
only partially defective in DSB repair (Bassing et al., 2002;
Celeste et al., 2002; Lou et al., 2006). Thus, the functional logic
of modifying megabases of flanking chromatin to protect the
genome against tiny breaks remains one of the most cryptic
aspects of the cellular DNA damage response (Cleaver, 2011;
Fernandez-Capetillo et al., 2003).
An outstanding question is whether MRN activates a similar
signaling response to protect the cell against viral DNA genomes
and cellular DSBs. A unifying feature of viruses is that they have
smaller genomes compared to their hosts. In principle, small viral
DNA genomes would not support the contiguous spreading of
DDR proteins across megabases of nucleosome-bound DNA
to induce global DNA damage signaling and cell-cycle arrest.
Given the daily onslaught we face from viruses, the induction
of cell-cycle arrest or apoptosis in response to viral DNA may
be untenable in terms of tissue homeostasis.
Ad5 encodes early viral proteins that target MRN through two
independent mechanisms (Figure 1A). E1B-55K binds to MRE11
and forms a complex with E4-ORF6 that targets MRE11 for
degradation in the proteasome (Querido et al., 2001; Stracker
et al., 2002). E4-ORF3 assembles a multivalent polymer network
in the nucleus that mislocalizes and sequesters MRN (Ou et al.,
2012; Stracker et al., 2002). The prevailing model is that MRN
inactivation is necessary to prevent the activation of a global
cellular DDR to adenovirus genomes (Carson et al., 2003; Weitz-
man et al., 2010). However, other studies have shown that a
global DDR is activated in Ad5-infected cells (Blackford et al.,Cell 162, 987–1002, August 27, 2015 ª2015 Elsevier Inc. 987
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2008; Forrester et al., 2011; Nichols et al., 2009). Thus, the role of
MRN and DDR signaling in virus infection remains contentious
and confounding.
Here, we show that MRN binds to viral genomes and activates
a localized ATM anti-viral response that prevents viral replica-
tion at the earliest stages. In contrast to cellular genome
breaks, MRN-ATM activation at viral genomes is not amplified
by gH2AX to induce a global DDR. This provides an elegant
mechanism to selectively arrest viral DNA replication without
jeopardizing cellular viability and proliferation. E1B-55K/E4-
ORF3 inactivate MRN and enable logarithmic virus genome
replication. The subsequent assembly of newly replicated virus
genomes in nuclear domains triggers global ATM signaling
through an MRN-independent mechanism but does not impact
viral replication.
RESULTS
E1B-55K and E4-ORF3 Inactivate MRN and Are Critical
for Viral Genome Replication
To determine the role of viral proteins that target MRN, we in-
fected quiescent primary human small airway epithelial cells
(SAECs) with wild-type Ad5 (WT) or viruses that have deletions
of E1B-55K and/or E4-ORF3 (Figures 1B and 1C; Figure S1A).
DE1 is a non-replicating vector control for virus infection that ex-
pressesGFP instead of viral genes. Previous studies have shown
that E1B-55K targets MRE11 for degradation in the proteasome
(Querido et al., 2001; Stracker et al., 2002). Consistent with
this, MRE11 and RAD50 protein levels are decreased in WT
and DE4-ORF3-virus-infected cells that express E1B-55K (Fig-
ure 1B). E4-ORF3 assembles a multivalent nuclear matrix that
binds and mislocalizes MRN (Ou et al., 2012). Thus, even in the
absence of E1B-55K-induced MRN degradation, E4-ORF3 se-
questers MRE11 and NBS1 in DE1B-55K-infected cells (Figures
1C and S1A). However, DE1B-55K/DE4-ORF3 viruses do not
degrade ormislocalizeMRNand enable its role in viral replication
to be determined (Figures 1B, 1C, and S1A).
In response to cellular DSBs, MRN activates global ATM
phosphorylation of DDR substrates (Ciccia and Elledge, 2010).
To determine whether MRN activates a global DDR to viral
genomes, we analyzed canonical ATM and DDR kinase
substrates in lysates from infected SAECs. As a positive con-
trol, we used doxorubicin to induce cellular DNA breaks. As
expected, cellular DNA damage triggers the global phos-
phorylation of DDR kinase substrates, including NBS1-Ser343,
ATM-Ser1981, H2AX-Ser139, KAP1-Ser824, RPA32-Ser4/
Ser8, and DNA-PKcs-Ser2056 (Figure 1D).Figure 1. E1B-55K and E4-ORF3 Inactivate MRN and Are Critical for
Signaling
(A) Adenovirus 5 (Ad5) early proteins target MRN through two independent mech
(B) Human small airway epithelial cells (SAECs) were infected with mock (DE1),
Protein lysates were collected at 24 hr post-infection (h.p.i.) and immunoblotted
specific and non-specific bands, respectively.
(C–E) SAECs were infected as indicated. (C) SAECs were fixed at 24 h.p.i. and
Hoechst. Nuclei are outlined in white. Scale bar, 10 mm. (D) Protein lysates were
cellular DNA damage. (E) Viral genomes were quantified by qPCR and normalize
(F) Virus genome replication domains were visualized in infected SAECs by E2A
See also Figure S1.However, contrary to expectations, MRNdoes not activate the
global phosphorylation of DDR kinase substrates in response to
virus genomes in DE1B-55K/DE4-ORF3-infected cells (Figures
1D and S1B). Furthermore, in WT, DE4-ORF3 and DE1B-55K-
infected cells, where MRN is inactivated by E1B-55K and/or
E4-ORF3, global DDR phosphorylated substrates are induced
(Figure 1D). These data suggest that global DDR signaling is acti-
vated independently of MRN in WT, DE1B-55K and DE4-ORF3-
virus-infected cells.
To determine whether there is a correlation between global
DDR signaling and virus genome replication, we harvested total
viral and cellular DNA. Virus genomes were quantified using
qPCR and normalized relative to cellular 18S rDNA. The levels
of virus genomes in WT, DE1B-55K, and DE4-ORF3-infected
cells are 104 times higher than in DE1B-55K/DE4-ORF3-virus-in-
fected cells (Figure 1E). We conclude that E1B-55K or E4-ORF3
is required for viral genome replication.
The replication of viral genomes is coincident with the
induction of global DDR phosphorylated substrates. In WT,
DE4-ORF3, and DE1B-55K-infected cells virus genomes are
concentrated in specialized domains in the nucleus demarcated
by the viral protein E2A (Figure 1F). The size and morphology of
E2A viral replication domains change over the course of the viral
life cycle (Boyer et al., 1957). In DE1B-55K/DE4-ORF3-virus-in-
fected cells, E2A is nuclear diffuse, indicating that viral genome
replication is blocked at the earliest stages (Figure 1F).
In vitro, adenovirus DNA replication does not require E1B-55K
and E4-ORF3 (Challberg and Kelly, 1979). This suggests that
E1B-55K/E4-ORF3 inactivate a cellular target that prevents early
virus DNA replication in vivo. A compelling overlapping candi-
date is MRN. Therefore, we determined whether MRN knock-
down rescues genome replication and activates global DDR
phosphorylation in DE1B-55K/DE4-ORF3-virus-infected cells.
The Inactivation of the MRN Complex Is Required for
Virus Genome Replication
The stable knockdown of MRN is lethal and primary SAECs are
refractory to transient small interfering RNA (siRNA) transfec-
tion. However, A549 cells are amenable to siRNA transfection.
Analogous to SAECs, in WT, DE4-ORF3, DE1B-55K but not
DE1B-55K/DE4-ORF3-infected A549 cells, global DDR kinase
phosphorylated substrates are induced (Figure 2A). Adenovirus
replication is accelerated by about 12 hr in A549 cells. However,
similar to SAECs, the levels of virus genomes are 104 times
higher in WT versus DE1B-55K/DE4-ORF3-infected A549 cells
(Figure 2B). Therefore, for experiments that required siRNA
transfection or large numbers of cells, we used A549 cells.Viral Genome Replication but Do Not Prevent Global DDR Kinase
anisms.
wild-type Ad5 (WT), DE4-ORF3, DE1B-55K, or DE1B-55K/DE4-ORF3 viruses.
as indicated. ‘‘t = 0’’ indicates uninfected cells. Arrows and asterisks indicate
stained for E4-ORF3 (green) and MRE11 (red). DNA was counterstained with
immunoblotted as indicated. Doxorubicin was used as a positive control for
d to 18S rDNA; error bars, SD (nd, not done).
immunofluorescence (green). Scale bar, 10 mm.
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Figure 2. The Inactivation of the MRN Complex Is Critical for Viral Genome Replication
(A and B) A549 cells were infected as indicated and harvested at 12, 24, and 36 h.p.i. (A) Protein lysates were immunoblotted as indicated. (B) Viral genomes were
quantified by qPCR; error bars, SD.
(C–F) A549 cells were transfectedwith either control siRNA (control) orMRE11 andRAD50 siRNAs (MR knockdown). Cells were infected 48 hr post transfection as
indicated. Mirin was added at 2 h.p.i. to control siRNA-treated cells. Protein lysates and DNA were harvested at 24 h.p.i. (C and E) Protein lysates were
immunoblotted as indicated. (D) Viral genomes were quantified by qPCR. (F) Total virus plaque-forming units (PFU) were quantified at 48 h.p.i. Error bars, SD of
triplicates.
See also Figure S2.
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We optimized two independent sets of siRNAs against MRE11
and RAD50 (MR knockdown) to knock down the MRN complex
(Figures S2A–S2C). We also used Mirin to inhibit MRE11 exonu-
clease activity (Dupre´ et al., 2008). In WT-virus-infected cells,
neither MR knockdown nor Mirin prevents the global phosphor-
ylation of DDR substrates (Figure 2C). Thus, the activation of
global DDR signaling in WT-virus-infected cells is MRN indepen-
dent and is not due to residual MRN expression or activity. MR
knockdown and Mirin have no effect on DDR phosphorylated
substrates in uninfected and DE1-infected cells (Figure 2C).
Strikingly, in DE1B-55K/DE4-ORF3-infected cells MR knock-
down, but not Mirin, induces the global phosphorylation of
DDR substrates (Figure 2C). To determine whether the phos-
phorylation is a downstream consequence of rescuing viral
genome replication, we quantified viral genomes. MR knock-
down rescues DE1B-55K/DE4-ORF3 virus genome replication
by over 1,000-fold toWT virus levels (Figure 2D). The knockdown
of individual MRN complex components is similar to the knock-
down of MRE11 and RAD50 together (Figures S2D and S2E). In
comparison, Mirin results in a nominal 1.9-fold rescue of DE1B-
55K/DE4-ORF3 virus genome replication (Figure 2D). These data
indicate that the MRN complex as opposed to MRE11 exonu-
clease activity prevents viral genome replication.
Adenovirus genome replication is required for the expression
of late viral proteins that form the capsid (Thomas and Mathews,
1980). In WT-virus-infected cells, MR knockdown and Mirin
do not further increase viral genome replication, late protein
expression, or virus titers (Figures 2D–2F). However,MR knock-
down results in a significant rescue of both capsid protein
expression and titers in DE1B-55K/DE4-ORF3-infected cells
(Figures 2E and 2F). A complete rescue is not expected as
E1B-55K and E4-ORF3 have additional functions in viral replica-
tion, such as p53 inactivation and late viral RNA export (O’Shea
et al., 2004; Soria et al., 2010).
We conclude that the MRN complex prevents virus genome
replication through a mechanism that does not activate global
ATM signaling or require MRE11 exonuclease activity. We
show that the inactivation of MRN enables virus genome replica-
tion and triggers downstream global DDR signaling.
The Assembly of Virus Replication Domains Activates
Global ATM Phosphorylation Independently of MRN
Adenovirus E1A induces both cellular and viral DNA replication.
E1A- and oncogene-induced replicative stress has been linked
to DNA damage signaling (Halazonetis et al., 2008; Singhal
et al., 2013). To determine whether viral or cellular DNA replica-
tion activates global DDR signaling, we exploited hydroxyurea
(HU) and aphidicolin. At low concentrations, aphidicolin inhibits
cellular but not virus DNA replication (Figures S3A–S3C). HU pre-
vents both cellular and virus DNA replication (Figures S3A–S3C).
We show that the inhibition of viral but not cellular DNA replica-
tion prevents ATM, H2AX, KAP1, RPA32, and DNA-PKcs phos-
phorylation in WT-virus-infected cells (Figure 3A). We conclude
that global DDR signaling is activated downstream of viral DNA
replication.
To determine whether viral DNA replication activates ATM
phosphorylation of global DDR substrates, we treated infected
cells with the ATM kinase inhibitor KU-55933 (Hickson et al.,2004). Similar to HU, KU-55933 prevents the phosphorylation
of ATM, H2AX, RPA32, and KAP1 inWT-virus-infected cells (Fig-
ure 3B). HU and KU-55933 also prevent the phosphorylation of
DNA-PKcs (Figure 3B), indicating that DNA-PK is activated
downstream of ATM in response to virus DNA replication. The
ATR kinase inhibitor, AZ20 (Foote et al., 2013), prevents the
induction of ATR and RAD17 phosphorylation, but not global
ATM phosphorylated substrates, such as ATM, H2AX, KAP1,
RPA32, and DNA-PKcs (Figure S3D).
We hypothesized that the assembly of virus genome domains
within the nucleus (Figure 1F) triggers the MRN-independent
activation of ATM. ATM activation triggers ATM autophosphory-
lation at Ser1981 (Bakkenist and Kastan, 2003). Etoposide in-
duces cellular DNA breaks and the phosphorylation of ATM at
discrete DDR foci (Figure 3C). Strikingly, ATM phosphoryla-
tion is also induced at nascent E2A viral genome replication
domains (Figure 3D). Phospho-ATM is concentrated toward
the center of nascent viral genome domains as well as immedi-
ately surrounding cellular chromatin (Figure 3E; Movie S1). How-
ever, in contrast to cellular DSBs, phospho-ATM is not retained
at mature E2A domains and diffuses throughout the nucleus
to induce global DDR phosphorylated substrates (Figure 3D). A
similar pattern is observed in WT-virus-infected A549 cells
(data not shown).
HU but not aphidicolin prevents viral genome replication and
the activation of ATMat E2A viral replication domains (Figure 3F).
Furthermore, treatment with KU-55933, but not AZ20 or Mirin,
prevents ATM phosphorylation at nascent E2A viral genome do-
mains (Figures 3G and S3E). Taken together, we conclude that
the assembly of nascent virus genome replication domains acti-
vates ATM through an MRN-independent mechanism.
To determine whether global ATM activation impacts virus
replication, we analyzed WT-virus-infected cells treated with
KU-55933 or DMSO. KU-55933 has no impact on WT virus
genome replication levels (Figure 3H). Furthermore, capsid pro-
tein expression and total virus titers are similar in WT-virus-
infected cells treated with DMSO, KU-55933, or AZ20 (Figures
S3F and S3G). ATM inhibition also does not impact the cyto-
pathic effect associated with WT virus replication (data not
shown). We conclude that the MRN-independent activation of
global ATM phosphorylation does not impact viral replication
(Figure 3I) in cell culture. Therefore, we focused on the critical
early MRN-dependent checkpoint that prevents viral genome
replication.
MRNSenses Replicating Virus Genomes and Activates a
Local ATM DDR that Prevents Viral DNA Replication
In the cellular DDR, MRN is the initial sensor that binds to DSBs
where it recruits and activates ATM (Figure 4A) (Ciccia and
Elledge, 2010). To determine whether MRN binds to adenovirus
genomes, we performedMRE11 chromatin immunoprecipitation
(ChIP) on A549 cells that had been infected with DE1, WT,
DE4-ORF3, DE1B-55K, or DE1B-55K/DE4-ORF3 viruses. Viral
genomes were quantified using primer sets that amplify the right
(PS1) and left (PS2) ends of virus genomes.
MRE11 binds to viral genomes in DE1B-55K/DE4-ORF3-
infected cells but not WT, DE4-ORF3, or DE1B-55K-infected
cells (Figure 4B). Thus, either MRN degradation by E1B-55K orCell 162, 987–1002, August 27, 2015 ª2015 Elsevier Inc. 991
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mislocalization by E4-ORF3 is sufficient to prevent MRN binding
to virus genomes (Figure 4B). Interestingly, MRE11 does not bind
to DE1 virus genomes (Figure 4B). DE1 is a replication-incompe-
tent vector (Figure 1E; Figure S4A). In contrast to DE1, DE1B-
55K/DE4-ORF3 viruses initiate limited replication as evidenced
by a 2- to 3-fold increase in viral genomes over the time course
of infection (Figures 1E and S4A). These data indicate that MRN
senses early replicating viral genomes.
To determine whether MRN recruits ATM to viral genomes, we
performed ChIP for MRE11 and ATM. We also performed
ChIP for epitopes with the preferred ATM and ATR SQ/TQ phos-
phorylated substrate motif (Kim et al., 1999). ATM and SQ/TQ
phosphorylated epitopes are enriched at viral genomes in
DE1B-55K/DE4-ORF3-infected cells but not WT or DE1-infected
cells (Figure 4C). We conclude that MRN recruits and activates
ATM phosphorylated substrates at viral genomes.
Despite the phosphorylation of ATM substrates at viral ge-
nomes (Figure 4C), global ATM phosphorylated substrates are
not induced in total lysates from DE1B-55K/DE4-ORF3-infected
cells (Figures 2A, 4D, S4B, and S4C). To determine whether
ATM activation at DE1B-55K/DE4-ORF3 viral genomes prevents
replication, we inhibited ATM with KU-55933. In parallel, we also
tested the AZ20 ATR kinase inhibitor since ATR and ATM phos-
phorylate substrates with similar SQ/TQ motifs. KU-55933, but
not AZ20, rescues DE1B-55K/DE4-ORF3 viral genome replica-
tion and titers in A549 cells (Figures 4E and 4F). Similarly, in
SAECs, KU-55933, and ATM small hairpin RNA (shRNA) rescue
DE1B-55K/DE4-ORF3 viral replication (Figures S4C–S4E). We
conclude that MRN activates a localized ATM DDR that restricts
viral genome replication.
MRN-ATM Activation at Viral Genomes Is Not Amplified
through gH2AX Foci and Global Signaling
At cellular DSBs, ATM signaling is amplified by the phosphoryla-
tion of H2AX acrossmegabases of chromatin (Polo and Jackson,
2011). MDC1 binds to gH2AX in a feedforward loop that recruits
additional MRN, DDR kinases, and effectors into foci that
facilitate global phosphorylation (Figure 5A). We hypothesized
that ATM activation at adenovirus genomes is not amplified
through H2AX phosphorylation and the assembly of DDR foci.
As a positive control, we used etoposide, which induces cellular
DNA damage and the assembly of NBS1, gH2AX, MDC1, and
53BP1 DDR foci, as expected (Figure 5B). However, in DE1B-
55K/DE4-ORF3-infected cells, the activation of MRN-ATM at
virus genomes does not induce the assembly of NBS1, gH2AX,Figure 3. The Assembly of Viral Genome Domains Activates Global AT
(A) SAECs were infected as indicated and treated with DMSO, hydroxyurea (HU
(B) SAECs were infected as indicated and treated with DMSO, HU, or the ATM k
positive control. Protein lysates were harvested and immunoblotted as indicated
(C) SAECs were treated with DMSO or etoposide for 12 hr and stained for Phosp
(D–G) WT-virus-infected cells were treated with DMSO, HU, aphidicolin, KU, or A
Phospho-ATM-Ser1981 (red). DNA was counterstained with Hoechst (blue). (D) R
mature E2A domains (lower). (E) 3D rendering, merge, and zoom of nascent E2A
AZ-treated WT-virus-infected cells. Scale bar, 10 mm.
(H) SAECs were infected as indicated and treated with DMSO or KU at 2 h.p.i. Vi
(I) Model: in WT, Ad5 infection E1B-55K/E4-ORF3 inactivate MRN and enable lo
domains activates global ATM phosphorylation but does not impact viral replica
See also Figure S3 and Movie S1.MDC1, and 53BP1 in DDR foci (Figure 5B; Figure S5). These
data are consistent with the absence of global DDR signaling
in DE1B-55K/DE4-ORF3-infected cells (Figure 1).
The adenovirus genome is only 36 kb, which by definition
precludes H2AX phosphorylation across megabases of chro-
matin. Adenovirus DNA is compacted by protein VII in capsids
but upon early gene transcription may associate with cellular
histones (Komatsu and Nagata, 2012). To compare the levels
of nucleosomes at cellular and viral genomes in infected cells,
we performed ChIP for histone H3 at multi-copy cellular Alu
sequences and adenovirus genome sequences. There is almost
five times more H3 associated with cellular versus adeno-
virus genomes in DE1 and DE1B-55K/DE4-ORF3-infected cells
(Figure 5C).
H2AX comprises approximately 10% of the H2A nucleosome
complement in cellular chromatin (Fernandez-Capetillo et al.,
2004). We hypothesized that the smaller genome size and lower
nucleosome occupancy of adenovirus genomes is below the
threshold for amplifying MRN-ATM activation through H2AX
phosphorylation and MDC1 recruitment. To test this, we per-
formed MRE11, gH2AX, and MDC1 ChIPs. gH2AX is below the
limits of detection at DE1B-55K/DE4-ORF3 viral genomes and
at background immunoglobulin G (IgG) levels (0.053% input)
(Figure 5D). MDC1 is enriched above background IgG levels
(0.24% input); however, normalizing relative to DE1 samples,
there is 4-fold more MRE11 than MDC1 at DE1B-55K/DE4-
ORF3 virus genomes (Figure 5D). We conclude that MRN-ATM
activation at viral genomes is not amplified through gH2AX to
induce DDR foci and a global cellular DDR.
Cellular DNA Damage Prevents MRN Binding and
Restriction of Virus Genome Replication
The role of MRN in responding to both cellular DSBs and virus
genomes has profound implications. We reasoned that the
recruitment of MRN to cellular DDR foci could sequester MRN
and prevent the cell sensing and restricting the replication of
virus genomes (Figure 6A). To test this, we used etoposide to
induce cellular DSBs in DE1B-55K/DE4-ORF3-infected cells. In
contrast to viral genomes, cellular genome breaks trigger
gH2AX and 53BP1 DDR foci in DE1B-55K/DE4-ORF3-infected
cells (Figure 6B). Importantly, these data demonstrate that
H2AX phosphorylation and the assembly of DDR foci are not
suppressed by viral proteins or infection. Instead, these data
indicate that viral genomes do not support the amplification of
MRN-ATM activation through gH2AX DDR foci. Thus, DDR fociM Phosphorylation Independently of MRN
), or aphidicolin at 2 h.p.i. Protein lysates were immunoblotted as indicated.
inase inhibitor KU-55933 (KU) at 2 h.p.i. Doxorubicin treatment was used as a
.
ho-ATM-Ser1981 (red). Scale bar, 10 mm.
Z20 (AZ) at 2 h.p.i. Cells were fixed at 18 h.p.i. and stained for E2A (green) and
epresentative images of WT-virus-infected cells with nascent (upper) and more
domains. (F) Aphidicolin and HU-treated WT-virus-infected cells. (G) KU and
rus genomes were quantified by qPCR at 48 h.p.i. Error bars, SD of triplicates.
garithmic viral genome replication. The assembly of viral genomes in nuclear
tion.
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discriminate viral and cellular genomes and determine whether a
local or global ATM response is more appropriate.
Strikingly, etoposide-induced cellular DNA damage rescues
the assembly of E2A domains in DE1B-55K/DE4-ORF3-infected
cells (Figure 6B). Consistent with this, using qPCR, we show that
virus genome replication is rescued by etoposide in a dose-
dependent manner (Figure 6C; Figure S6A). A similar rescue of
virus genome replication is observed in DE1B-55K/DE4-ORF3-
infected SAECs that tolerate higher concentrations of etoposide
and doxorubicin (Figures S6B and S6C). In contrast, the induc-
tion of cellular DNA damage has no effect on the levels of WT
virus genome replication (Figure S6D).
In addition to etoposide, we also used bleomycin, which
induces cellular DNA damage through a distinct mechanism
(Povirk, 1996). Both etoposide and bleomycin rescue DE1B-
55K/DE4-ORF3 viral genome replication, despite the activation
of global DDR kinase signaling (Figures 6D and 6E). Thus,
localized but not global ATM activation prevents virus genome
replication.
To determine whether cellular DSBs compete for MRN bind-
ing, we performed MRE11 ChIP. We show that MRE11 recruit-
ment to viral genomes is inhibited by the concomitant induction
of cellular DNA damage in DE1B-55K/DE4-ORF3-infected cells
treated with etoposide or bleomycin (Figure 6F). Similar conclu-
sions were obtained with doxorubicin treatment (Figure S6E).
These data demonstrate that the binding of MRN and activation
of a localized ATM response prevents viral genome replication.
Furthermore, the induction of cellular DNA breaks sequesters
MRN and prevents the restriction of viral replication.
The Localized MRN-ATM Anti-viral DDR Prevents Viral,
but Not Cellular, Replication
DDR foci play an important role in amplifying global DDR
signaling, so that even a single DSB is sufficient to elicit cell-
cycle arrest (Polo and Jackson, 2011). To determine whether
the localized MRN-ATM anti-viral DDR specifically prevents
viral but not cellular DNA replication, we analyzed S phase
entry in quiescent SAECs that had been infected with DE1,
WT, DE4-ORF3, DE1B-55K, and DE1B-55K/DE4-ORF3 viruses.
In contrast to DE1-virus-infected cells, WT, DE4-ORF3, DE1B-
55K, and DE1B-55K/DE4-ORF3 virus infections all induce
S phase entry to equivalent levels (Figure 7A). Consistent with
this, CYCLIN A and CYCLIN B are also induced (Figure 7B).
We also examined whether the localized MRN-ATM anti-viral
response is uncoupled frommitotic arrest.We seeded A549 cells
infected withDE1 orDE1B-55K/DE4-ORF3 viruses at subconflu-
ent densities and stained for Phospho-H3-Ser10 and mitotic
bodies. Despite the activation of MRN-ATM at virus genomes
(Figures 2D, 4B, and 4C), DE1B-55K/DE4-ORF3-infected cells
induce Phospho-H3-Ser10 and form mitotic bodies (Figure 7C).
To determine whether activation of the MRN-ATM anti-viral
DDR induces a subsequent cell-cycle arrest, we performed a(C) A549 cells were infected as indicated and harvested at 12 h.p.i. ChIP was perfo
plotted as fold enrichment relative to DE1 samples.
(D–F) A549 cells were infected as indicated and treatedwith DMSO (–), KU, or AZ2
(E) Virus genomes at 24 h.p.i. were quantified by qPCR. (F) Total virus plaque-fo
See also Figure S4.population doubling analysis of infected cells over 4 days. WT
virus undergoes productive lytic replication that kills infected
cells after 2 days (Figure 7D). However, DE1B-55K/DE4-ORF3-
infected cells double at similar rates to uninfected cells (Fig-
ure 7D). Thus, the localized MRN-ATM anti-viral DDR selectively
prevents viral replication and maintains cellular proliferative
potential.
DISCUSSION
Our studies identify a critical localized MRN-ATM response that
prevents viral replication and is inactivated by viral oncoproteins.
In contrast to chromosomal DSBs, MRN-ATM activation at
virus genomes is not amplified across megabases of chromatin
by gH2AX to trigger the assembly of DDR foci, global signaling
and cell-cycle arrest. The localized MRN-ATM response pro-
vides an elegant mechanism to selectively neutralize viral repli-
cation without jeopardizing cellular replication and viability.
Our data provide the following model (Figure 7E). MRN senses
and binds to early replicating virus genomes where it recruits
ATM and activates a localized signaling response that selec-
tively prevents virus genome replication. In WT Ad5-infected
cells, E1B-55K and E4-ORF3 inactivate MRN and enable virus
genome replication. The assembly of virus genomes in nascent
domains within the nucleus triggers the MRN-independent acti-
vation of ATM. ATM diffuses throughout the nucleus and induces
global DDR phosphorylated substrates. However, in contrast to
the localized MRN-ATM anti-viral DDR at viral genomes, global
ATM phosphorylation does not impact viral replication.
The existence of two temporally distinct ATM DDRs to adeno-
virus genome replication reconciles the confounding observa-
tions of numerous studies. The majority of previous studies
used E4-deleted viruses in cancer cell lines (Carson et al.,
2003, 2009; Gautam and Bridge, 2013; Mathew and Bridge,
2007, 2008; Stracker et al., 2002). In contrast to DE1B-55K/
DE4-ORF3 viruses, E4-deleted viruses express E1B-55K and
induce the assembly of mature E2A virus genome replication do-
mains. E1B-55K can bind to MRE11 in the absence of E4-ORF6
(Carson et al., 2003), which may be sufficient to inactivate the
early MRN checkpoint to viral genome replication.
Our studies reveal adenovirus infection as a powerful system
to identify MRN-independent mechanisms that activate ATM.
MRN is generally thought to be critical for ATM activation (Ciccia
and Elledge, 2010). However, in WT-virus-infected cells, ATM is
activated at viral replication domains despite MRN degradation
by E1B-55K/E4-ORF6 and sequestration by E4-ORF3 (Figures
1A–1D). Furthermore, neither MR siRNA knockdown nor Mirin
prevents ATM activation in WT-virus-infected cells (Figure 2C).
We show that ATM is activated and phosphorylated at nascent
E2A viral genome replication domains (Figure 3D). Phospho-
ATM is induced at the center of nascent viral domains as well
as immediately surrounding cellular chromatin (Figure 3E; Moviermed usingMRE11, ATM, and Phospho-SQ/TQ substrate motif antibodies and
0 (AZ) at 2 h.p.i. (D) Protein lysates at 24 h.p.i. were immunoblotted as indicated.
rming units (PFUs) at 48 h.p.i. Error bars, SD of triplicates.
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S1). Previous studies have shown that the disruption of cellular
chromatin can activate ATM (Bakkenist and Kastan, 2003).
This raises the intriguing possibility that the assembly of virus
genomes in nuclear domains is sensed through the disruption
of surrounding cellular chromatin. In contrast to cellular DNA
breaks (Figure 3C) (So et al., 2009), phospho-ATM is not retained
at E2A domains (Figure 3D) and diffuses throughout the nucleus
where it phosphorylates global cellular DDR substrates. In
contrast to the localized MRN-dependent activation of ATM at
virus genomes, global ATM phosphorylation has no impact on
viral genome replication, capsid protein expression, or total virus
titers (Figures 3H, S3F, and S3G). However, global ATM signaling
could play an important role in vivo in modulating the host im-
mune response to virus infection (Brzostek-Racine et al., 2011;
Gasser and Raulet, 2006; Mboko et al., 2012).
We show that either E1B-55K or E4-ORF3 is sufficient to pre-
vent MRN binding to virus genomes (Figure 4B). The prevailing
model is that the linear ends of adenovirus genomes resemble
cellular DSBs and are targets for MRN binding (Stracker et al.,
2002; Weitzman et al., 2010). However, TP/pTP is covalently
attached to the 50 ends of adenovirus genomes (Rekosh et al.,
1977). We show that MRE11 binds to viral genomes in DE1B-
55K/DE4-ORF3 but not DE1-virus-infected cells (Figures 4B,
4C, 5D, 6F, and S6E). In contrast to DE1 vectors, DE1B-55K/
DE4-ORF3 viruses undergo limited genome replication (Figures
1E, 2B, and S4A). The initial replication of adenovirus genomes
is semi-conservative, similar to cellular DNA. These data suggest
that MRN specifically senses early replicating as opposed to
incoming viral genomes.
MRE11 nuclease activity plays a critical role in the response to
cellular DSBs and DNA repair (Stracker and Petrini, 2011) and is
inhibited by Mirin (Dupre´ et al., 2008). In contrast to the siRNA-
mediated knockdown of MRN, Mirin has a nominal impact
in rescuing DE1B-55K/DE4-ORF3 virus genome replication
(Figures 2D and S2E). Thus, the binding of the MRN complex
as opposed to MRE11 exonuclease activity protects the cell
against viral replication. MRN recruits and activates ATM phos-
phorylated substrates at viral genomes (Figure 4C). ATM kinase
inhibitors rescue DE1B-55K/DE4-ORF3 viral replication (Figures
4E and S4D) but to a lesser extent than MRN knockdown (Fig-
ures 2D andS2E). These data indicate that ATMhas an important
albeit subsidiary role to MRN binding in preventing viral genome
replication. We favor themodel that MRN binding near viral repli-
cation origins (located at both ends of the adenovirus genome)
physically prevents the progression of viral DNA replication.
Our studies suggest a role for DDR foci and the logic of modi-
fying vast tracts of chromatin flanking a cellular DSB (Polo and
Jackson, 2011). There are universal and absolute differences be-Figure 5. MRN-ATM Activation at Viral Genomes Is Not Amplified by H
(A) At cellular genomes ATM activation is amplified by H2AX phosphorylation tha
small viral genomes meet the threshold for amplifying ATM activation through H
(B) A549 cells were treated as indicated, fixed at 12 h.p.i. and stained for E2A (gree
were identified by GFP expression. Scale bar, 10 mm.
(C) A549 cells were infected as indicated and harvested at 12 h.p.i. ChIP was perfo
Alu sequences were quantified by qPCR.
(D) A549 cells were infected as indicated and harvested at 12 h.p.i. ChIP was perfo
were quantified by qPCR. See also Figure S5.tween the sizes, chromatin composition, and diffusion of viral
and cellular genomes. The entire adenovirus genome is only 36
kb and associated with protein VII in viral capsids (Knipe and
Howley, 2013). We show that there are less nucleosomes
associated with viral versus cellular genomes in infected cells
(Figure 5C). The latter could prevent chromatin compaction,
which plays an important role in the assembly of DDR foci (Ayr-
apetov et al., 2014; Burgess et al., 2014; Khurana et al., 2014).
H2AX is prepositioned not recruited to chromatin flanking
cellular DSBs. gH2AX is also below the limits of detection at
DE1B-55K/DE4-ORF3 viral genomes (Figure 5D). Furthermore,
in contrast to cellular chromosomal breaks (Soutoglou et al.,
2007), adenovirus genomes diffuse throughout the nucleus
(Pombo et al., 1994), which may impair the assembly of stable
DDR domains. Thus, viral genomes may not meet several
threshold criteria for the assembly of DDR foci. An alternative
explanation is that viral infection or proteins prevent the assem-
bly of DDR foci and signaling. However, in contrast to MRN-ATM
activation at viral genomes, cellular genome breaks trigger the
assembly of gH2AX DDR foci and global signaling in DE1B-
55K/DE4-ORF3-infected cells (Figures 5 and 6B). Thus, gH2AX
DDR foci function as a diagnostic device to discriminate MRN-
ATM activation at self and non-self genomes to determine
whether a localized ATM anti-viral DDR or global cellular DDR
is more appropriate.
DDR foci amplify global DNA damage signaling such that even
a single cellular DSB is sufficient to induce cell-cycle arrest and
repair (Bennett et al., 1993). However, the localized anti-viral
DDR selectively prevents viral genome replication but not cellular
replication and division (Figures 1 and 7). Adenovirus genomes
do not integrate into cellular DNA and are lost upon nuclear
membrane breakdown. The localized anti-viral DDR arrests viral
genome replication while enabling cellular replication to poten-
tially purge viral genomes from the nucleus.
The reliance of both the anti-viral and cellular DDR on MRN
sensing has profound consequences and is susceptible to satu-
ration. We show that the induction of cellular DNA damage by
genotoxic drugs rescues DE1B-55K/DE4-ORF3 viral genome
replication in a dose-dependent manner (Figure 6). Cellular
DNA breaks compete with virus genomes for MRN binding and
saturate MRN’s capacity to restrict viral genome replication
(Figure 6). This has important implications for virus infections in
pathological conditions where genotoxic stress is common,
such as cancer and aging (Jackson and Bartek, 2009). Telomere
shortening is a hallmark of aging that could sequester MRN and
render ‘‘old’’ cells more permissive for viral replication (Suram
and Herbig, 2014). The prevalence of virus infections, including
adenovirus, is a serious and often fatal complication in cancer2AX to Induce DDR Foci and Global Signaling
t recruits MDC1 and DDR proteins into nuclear foci. A key question is whether
2AX.
n) and NBS1 (red), gH2AX (red), MDC1 (red), or 53BP1 (red).DE1-infected cells
rmed using histone H3 antibodies or an IgG control. Virus genomes and cellular
rmed usingMRE11, gH2AX,MDC1, and IgG control antibodies. Virus genomes
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Figure 6. Cellular DNA Damage Prevents MRN Sensing and Restriction of Viral Genome Replication
(A) Model: cellular DSBs compete for MRN binding and prevent MRN restriction of viral genome replication.
(B) A549 cells were infected with DE1B-55K/DE4-ORF3 and treated with DMSO or 10 mg/ml etoposide at 2 h.p.i. Cells were fixed at 12 h.p.i. and co-stained for
E2A (green) and gH2AX or 53BP1 (red). Scale bar, 10 mm.
(C) A549 cells were infected with DE1B-55K/DE4-ORF3 and treated with different concentrations of etoposide at 6 h.p.i. and harvested at 24 h.p.i. Virus genomes
were quantified by qPCR.
(D and E) A549 cells were infected as indicated and treated with DMSO (–), 30 mg/ml etoposide, or 10 mM bleomycin at 6 h.p.i. Protein lysates and DNA were
harvested at 24 h.p.i. (D) Virus genomes were quantified by qPCR. (E) Protein lysates were immunoblotted as indicated.
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patients treated with chemotherapy, especially in the case of
children (Hough et al., 2005; Lee et al., 2014; Steiner et al.,
2008). DNA damage is one of the earliest hallmarks of cancer
(Halazonetis et al., 2008) and could explain the permissiveness
of many tumor cell lines for DE1B-55K/DE4-ORF3 viral genome
replication (G.A.S. and C.C.O., unpublished data). Thus, our
studies provide key mechanistic insights that could enable the
development of E1B-55K/E4-ORF3 mutant viruses as novel
cancer therapies (O’Shea, 2005) that selectively replicate in pre-
cancerous lesions and tumor cells that have high levels of DNA
damage. These viral agents could also be exciting and rational
combination therapies with drugs that selectively agonize or
antagonize DDR pathways dysregulated in cancer (Curtin, 2012).
Viruses are one of the most ancient and persistent threats to
cellular genome integrity from single-cell to long-lived multicel-
lular organisms. To date, studies of an anti-viral role for MRN
and DDR signaling have been predicated on the well-established
response to cellular DSBs and hostage to its assays, namely, the
induction of DDR foci and global signaling. Here, we show that
the critical MRN-ATM anti-viral DDR exhibits neither hallmark
and is uncoupled from the cellular DDR. It will be interesting
to determine whether this is peculiar to adenovirus or extends
to other DNA viruses and extrachromosomal DNA. Adenovirus
is thought to be a descendant of phage and some relation of it
has been with us for a long time (Hendrix, 1999). There are 68 hu-
man adenoviruses. However, the evolution of independent sets
of viral proteins that inactivate MRN appears to be a recent
evolutionary innovation of subgroup C viruses, such as Ad5
and 2 (Carson et al., 2009; Cheng et al., 2013; Forrester et al.,
2011), which are among the most prevalent in the population.
The ratio of virus particles with partial or defective genomes to
infectious virus particles is approximately 50:1, even with highly
purified laboratory preparations. If every incoming and defective
viral genome activated global DDR signaling and cell-cycle ar-
rest or death, it would present a severe threat to cell growth
and tissue homeostasis, especially during early development
and wound healing. Our study suggests that the assembly of
DDR foci distinguishes MRN-ATM activation at self and non-
self genomes, which may be a critical adaptation in ensuring
an appropriate and proportional response.
EXPERIMENTAL PROCEDURES
Cell Culture and Viruses
Human small airway epithelial cells (SAECs) and A549 cells were cultured as
previously described (Soria et al., 2010) and infected at a MOI of ten plaque-
forming units (PFUs). Titers of virus stocks and total virus production in in-Figure 7. The Localized MRN-ATM Anti-viral DDR Specifically Prevent
(A) SAECs were infected as indicated, fixed at 48 h.p.i., stained with propidium
content >2N is indicated.
(B) SAECs were infected and immunoblotted as indicated.
(C) A549 cells were treated as indicated, fixed at 24 h.p.i., and stained for themitot
by E2A staining or GFP (green). DNA was counterstained with Hoechst (blue). Sc
(D) A549 cells were untreated or infected as indicated. Population doublings are
(E) Model: at cellular DSBs MRN-ATM activation is amplified by H2AX to induce
local ATM DDR that prevents viral but not cellular genome replication (middle). In W
of virus genomes in nuclear domains activates ATM independently of MRN. ATM
impact virus replication.
1000 Cell 162, 987–1002, August 27, 2015 ª2015 Elsevier Inc.fected cells were quantified in 293/E4/pIX cells (O’Shea et al., 2004). For a
description of viruses used in these studies, see Supplemental Experimental
Procedures.
Drugs
Unless otherwise stated, doxorubicin (Sigma) was used at 0.5 mg/ml, etopo-
side (Sigma) at 30 mg/ml, hydroxyurea (Sigma) at 2 mM, aphidicolin (Sigma)
at 1 mM, KU-55933 (Calbiochem) at 10 mM, AZ20 (ApexBio) at 3 mM, bleomycin
(Sigma) at 10 mM, and Mirin (Santa Cruz Biotechnology) at 20 mM.
siRNA
Stealth siRNAs (Life Technologies) were transfected using PepMute Plus
(Signagen). Virus infection was performed 48 hr after transfection of siRNAs.
See Supplemental Experimental Procedures.
Immunofluorescence
Cells were stained as described previously (O’Shea et al., 2004). Images were
acquired with a Zeiss LSM780 imaging system. See Supplemental Experi-
mental Procedures.
Immunoblot
Lysates from an equal number of cells were analyzed by SDS-PAGE and
immunoblotting (Ou et al., 2012). Protein levels were quantified using a LI-COR
Odyssey scanner.
Quantification of Viral Genome Replication
Viral genomes were quantified using TaqMan probes (Johnson et al., 2002)
and normalized relative to cellular 18S rDNA. See Supplemental Experimental
Procedures.
Chromatin Immunoprecipitation
ChIP was performed as described previously (Soria et al., 2010). Virus and
cellular genome sequences were quantified by qPCR. See Supplemental
Experimental Procedures.
Cell-Cycle Analysis
SAECs were stained with propidium iodide/RnaseA, and cellular DNA content
was analyzed using flow cytometry (O’Shea et al., 2004).
Population Doubling Analysis
A549 cells were seeded at subconfluent densities and counted at the indicated
time to calculate population doublings. See Supplemental Experimental
Procedures.
Antibodies
For information about antibodies, see table in Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and one movie and can be found with this article online at http://
dx.doi.org/10.1016/j.cell.2015.07.058.s Viral, but Not Cellular, Replication
iodide, and analyzed by flow cytometry. The percentage of cells with DNA
ic marker, Phospho-H3-Ser10 (P-H3-Ser10) (red). Infected cells were identified
ale bar, 10 mm.
plotted against h.p.i. Error bars, SD of triplicates.
global DDR signaling and arrest (left). At small viral genomes MRN activates a
T Ad5 infection, MRN is inactivated by E1B-55K and E4-ORF3. The assembly
phosphorylates global DDR substrates throughout the nucleus but does not
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